Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Author's Avatar
Nov 11, 2022

Total revenue of $1.7 million in Q3 including sale of 3,100 disposable treatment tips
PURSUIT clinical trial completion expected by year-end
Conference call to be hosted by Company at 5:00 PM ET today